New Delhi: The government has approved strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL) to Skymap Pharmaceuticals Pvt Ltd for over Rs 121 crore, the finance ministry said on Tuesday.
The government had received two financial bids for buying 100 per cent stake, along with management control, in IMPCL, and among them, M/s. Skymap Pharmaceuticals Pvt Ltd has emerged as the highest bidder at Rs 121,00,94,400, which was also above the reserve price, the ministry said in a statement.